0 CHECKOUT

In Vitro Toxicology Testing Market by Product, Type, Toxicity Endpoints & Tests, Technology, Method, Industry - Global Forecast to 2021

  • ID: 3757794
  • June 2016
  • Region: Global
  • 257 Pages
  • Markets and Markets
1 of 5
The Global In Vitro Toxicology Testing Market is Expected to Reach USD 27.36 Billion by 2021 from USD 14.15 Billion in 2016 at a CAGR of 14.1%

FEATURED COMPANIES

  • Catalent
  • Covance
  • Cyprotex
  • Eurofins Scientific SE
  • General Electric Company
  • MORE

"In Vitro Toxicology Testing Market by Product, Type (ADME), Toxicity Endpoints & Tests (Carcinogenicity, Dermal Toxicity, Genotoxicity), Technology (Genomics, Transcriptomics), Method (Cellular Assays), Industry (Pharmaceutical) - Global Forecast to 2021"

Toxicity testing of new compounds is essential in drug development, as identifying the potential toxicity at an early stage in drug discovery can save both time and developmental costs, and also reduce the likelihood of late-stage failure.

Opposition to animal testing, new & promising technologies, increasing R&D to detect toxicity at early stages and insufficient databases to facilitate the use of in vitro test methods are driving factors of the in vitro toxicology testing market. On the other hand lack of in vitro models to detect autoimmunity and immunostimulation and predictive ability of in vitro testing over in vivo testing are the major factor restraining the growth of this market.

This report segments the global in vitro toxicology testing market by product, type, toxicity endpoints & tests, technology, method, industry, and geography. By product, the market includes assays, reagents & READ MORE >

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Catalent
  • Covance
  • Cyprotex
  • Eurofins Scientific SE
  • General Electric Company
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Segmentation
1.3.1 Years Considered in the Report
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights
4.1 Global Market Overiew
4.2 Market: By Technology & Region
4.3 Market: Geographic Snapshot
4.4 Life Cycle Analysis, By Region (2016)

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Opposition to Animal Testing
5.3.1.2 New and Promising Technologies
5.3.1.3 Increasing R&D to Detect Toxicity at Early Stages
5.3.1.4 Insufficient Databases to Facilitate the Use of In Vitro Test Methods
5.3.2 Restraints
5.3.2.1 Predictive Ability of In Vitro Testing Leads to Decreasing Adoption of These Tests
5.3.2.2 Lack of In Vitro Models to Detect Autoimmunity & Immunostimulation
5.3.3 Opportunities
5.3.3.1 Growing Demand for In Vitro Toxicology in the European Market
5.3.3.2 Toxicology in the 21st Century (Tox21) Program
5.3.3.3 Increasing Drug Discovery and Innovation & Modernization in the In Vitro Toxicity Testing Market
5.3.4 Threat
5.3.4.1 Reluctance of Regulatory Authorities to Consider Alternate Methods for Proving Safety and Efficacy

6 Industry Insights
6.1 Introduction
6.1.1 Increasing R&D Spending in Pharmaceutical and Biotechnology Sector
6.2 Key Focus Area
6.2.1 New and Promising Technological Advancements A Key Area of Focus for Market Players
6.3 Supply Chain Analysis
6.4 Porter’s Five Forces Analysis
6.4.1 Threat From New Entrants
6.4.2 Threat From Substitutes
6.4.3 Bargaining Power of Suppliers
6.4.4 Bargaining Power of Buyers
6.4.5 Intensity of Competitive Rivalry
6.5 Regulatory Committee Activities

7 In Vitro Toxicology Testing Market, By Product
7.1 Introduction
7.2 Assays
7.2.1 Bacterial Toxicity Assays
7.2.2 Enzyme Toxicity Assays
7.2.3 Cell-Based Elisa and Western Blots
7.2.4 Receptor-Binding Assays
7.2.5 Tissue Culture Assays
7.2.6 Other Assays
7.3 Services
7.4 Reagents & Labware

8 In Vitro Toxicology Testing Market, By Type
8.1 Introduction
8.2 ADME (Absorption, Distribution, Metabolism, and Excretion)
8.3 Dose
8.3.1 Dose Response
8.3.2 Threshold Response
8.4 Toxic Substance

9 In Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests
9.1 Introduction
9.2 Systemic Toxicity
9.3 Dermal Toxicity
9.4 Carcinogenicity
9.5 Ocular Toxicity
9.6 Skin Sensitization & Irritation
9.7 Genotoxicity
9.8 Neurotoxicity
9.9 Organ Toxicity
9.10 Other Toxicity Endpoints & Tests

10 In Vitro Toxicology Testing Market, By Technology
10.1 Introduction
10.2 OMICS Technologies
10.2.1 Genomics
10.2.2 Proteomics
10.2.3 Metabolomics
10.2.4 Transcriptomics
10.2.5 Toxicogenomics
10.3 Cell Culture Technology
10.4 High-Throughput Technologies
10.5 Molecular Imaging Technologies

11 In Vitro Toxicology Testing Market, By Method
11.1 Introduction
11.2 In Silico Methods
11.3 Biochemical Assays
11.4 Cellular Assays
11.5 Ex Vivo Models

12 In Vitro Toxicology Testing Market, By Industry
12.1 Introduction
12.2 Cosmetics and Household Products
12.3 Diagnostics
12.3.1 Urine Screening
12.3.2 Alcohol Screening
12.3.3 Oral Fluid Screening
12.3.4 Hair Screening
12.3.5 Others
12.4 Pharmaceuticals
12.5 Food Industry
12.6 Chemicals

13 In Vitro Toxicology Testing Market, By Region
13.1 Introduction
13.2 Europe
13.3 North America
13.3.1 U.S.
13.3.2 Canada
13.4 Asia
13.5 Rest of the World

14 Competitive Landscape
14.1 Introduction
14.2 Strategic Analysis
14.3 Leading Players in the Market
14.4 Competitive Situation and Trends
14.4.1 New Product Launches and Product Upgrades
14.4.2 Acquisition
14.4.3 Agreements, Collaborations, and Partnerships
14.4.4 New Service Launch
14.4.5 Expansion
14.4.6 Other Developments

15 Company Profiles
(Overview, Financial*, Products & Services, Strategy, and Developments)
15.1 Introduction
15.2 Agilent Technologies, Inc.
15.3 Covance
15.4 Bio-Rad Laboratories, Inc.
15.5 General Electric Company
15.6 Eurofins Scientific SE
15.7 Bioreliance, Inc. (A Subsidiary of Merck & Co, Inc.)
15.8 Thermo Fisher Scientific, Inc.
15.9 Charles River Laboratories International, Inc.
15.10 Catalent
15.11 Cyprotex

*Details Might Not Be Captured in Case of Unlisted Companies.

16 Appendix
16.1 Insights of Industry Experts
16.2 Discussion Guide
16.3 Other Developments

List of Tables

Table 1 In Vitro Toxicology Testing Market Summary
Table 2 Opposition to Animal Testing is Propelling the Growth of the Market
Table 3 Predictive Ability of In Vitro Testing Leading to the Decreasing Adoption of In Vitro Tests is Restricting Market Growth
Table 4 New Research Initiatives and Growing Demand for In Vitro Toxicology in the European Market to Offer Significant Growth Opportunities for Players in the Market
Table 5 Reluctance of Regulatory Authorities to Consider Alternate Methods is A Major Threat for This Marker
Table 6 In Vitro Toxicology Testing Industry Focusing on Technological Advancements to Drive Toxicity Endpoints Testing
Table 7 Market Size, By Product, 2014 - 2021 (USD Million)
Table 8 Market Size for Assays, By Type, 2014 - 2021 (USD Million)
Table 9 Market Size for Assays, By Region, 2014 - 2021 (USD Million)
Table 10 Market Size for Bacterial Toxicity Assays, By Region, 2014 - 2021 (USD Million)
Table 11 In Vitro Toxicity Testing Market Size for Enzyme Toxicity Assays, By Region, 2014 - 2021 (USD Million)
Table 12 Market Size for Cell-Based Elisa and Western Blots, By Region, 2014 - 2021 (USD Million)
Table 13 Market Size for Receptor-Binding Assays, By Region, 2014 - 2021 (USD Million)
Table 14 Market Size for Tissue Culture Assays, By Region, 2014 - 2021 (USD Million)
Table 15 Market Size for Other Assays, By Region, 2014 - 2021 (USD Million)
Table 16 Market Size for Services, By Region, 2014 - 2021 (USD Million)
Table 17 Market Size for Reagents & Labware, By Region, 2014 - 2021 (USD Million)
Table 18 Market Size, By Type, 2014 - 2021 (USD Million)
Table 19 Market Size for ADME, By Region, 2014 - 2021 (USD Million)
Table 20 Market Size for Dose, By Type, 2014 - 2021 (USD Million)
Table 21 Market Size for Dose, By Region, 2014 - 2021 (USD Million)
Table 22 Market Size for Dose Response, By Region, 2014 - 2021 (USD Million)
Table 23 Market Size for Threshold Response, By Region, 2014 - 2021 (USD Million)
Table 24 Market Size for Toxic Substances, By Region, 2014 - 2021 (USD Million)
Table 25 Market Size, By Toxicity Endpoint & Test, 2014 - 2021 (USD Million)
Table 26 Market Size for Systemic Toxicity, By Region, 2014 - 2021 (USD Million)
Table 27 Market Size for Dermal Toxicity, By Region, 2014 - 2021 (USD Million)
Table 28 Market Size for Carcinogenicity, By Region, 2014 - 2021 (USD Million)
Table 29 Market Size for Ocular Toxicity, By Region, 2014 - 2021 (USD Million)
Table 30 Market Size for Skin Sensitization & Irritation Market, By Region, 2014 - 2021 (USD Million)
Table 31 Market Size for Genotoxicity, By Region, 2014 - 2021 (USD Million)
Table 32 Market Size for Neurotoxicity, By Region, 2014 - 2021 (USD Million)
Table 33 Market Size for Organ Toxicity, By Region, 2014 - 2021 (USD Million)
Table 34 Market Size for Other Toxicity Endpoints & Tests, By Region, 2014 - 2021 (USD Million)
Table 35 Market Size, By Technology, 2014 - 2021 (USD Million)
Table 36 Market Size for OMICS Technologies, By Type, 2014 - 2021 (USD Million)
Table 37 Market Size for OMICS Technologies, By Region, 2014 - 2021 (USD Million)
Table 38 Market Size for Genomics, By Region, 2014 - 2021 (USD Million)
Table 39 Market Size for Proteomics, By Region, 2014 - 2021 (USD Million)
Table 40 Market Size for Metabolomics Market, By Region, 2014 - 2021 (USD Million)
Table 41 Market Size for Transcriptomics, By Region, 2014 - 2021 (USD Million)
Table 42 Market Size for Toxicogenomics, By Region, 2014 - 2021 (USD Million)
Table 43 Market Size for Cell Culture Technology, By Region, 2014 - 2021 (USD Million)
Table 44 Market Size for High-Throughput Technologies, By Region, 2014 - 2021 (USD Million)
Table 45 Market Size for Molecular Imaging Technologies, By Region, 2014 - 2021 (USD Million)
Table 46 Market Size, By Method, 2014 - 2021 (USD Million)
Table 47 Market Size for In Silico Methods, By Region, 2014 - 2021 (USD Million)
Table 48 Market Size for Biochemical Assays, By Region, 2014 - 2021 (USD Million)
Table 49 Market Size for Cellular Assays, By Region, 2014 - 2021 (USD Million)
Table 50 Market Size for Ex Vivo Assays, By Region, 2014 - 2021 (USD Million)
Table 51 Market Size, By Industry, 2014 - 2021 (USD Million)
Table 52 Market Size for Cosmetics & Household Products, By Region, 2014 - 2021 (USD Million)
Table 53 Market Size for Diagnostics, By Type, 2014 - 2021 (USD Million)
Table 54 Market Size for Diagnostics, By Region, 2014 - 2021 (USD Million)
Table 55 Market Size for Urine Screening, By Region, 2014 - 2021 (USD Million)
Table 56 Market Size for Alcohol Screening, By Region, 2014 - 2021 (USD Million)
Table 57 Market Size for Oral Fluid Screening, By Region, 2014 - 2021 (USD Million)
Table 58 Market Size for Hair Screening, By Region, 2014 - 2021 (USD Million)
Table 59 Market Size for Other Diagnostics, By Region, 2014 - 2021 (USD Million)
Table 60 Market Size for Pharmaceuticals, By Region, 2014 - 2021 (USD Million)
Table 61 Market Size for the Food Industry, By Region, 2014 - 2021 (USD Million)
Table 62 Market Size for the Chemical Industry, By Region, 2014 - 2021 (USD Million)
Table 63 Market Size, By Region, 2014 - 2021 (USD Million)
Table 64 Europe: Market Size, By Product, 2014 - 2021 (USD Million)
Table 65 Europe: Market Size, By Type, 2014 - 2021 (USD Million)
Table 66 Europe: Market Size, By Toxicity Endpoint & Test, 2014 - 2021 (USD Million)
Table 67 Europe: Market Size, By Technology, 2014 - 2021 (USD Million)
Table 68 Europe: Market Size, By Method, 2014 - 2021 (USD Million)
Table 69 Europe: Market Size, By Industry, 2014 - 2021 (USD Million)
Table 70 North America: Market Size, By Country, 2014 - 2021 (USD Million)
Table 71 North America: Market Size, By Product, 2014 - 2021 (USD Million)
Table 72 North America: Market Size, By Type, 2014 - 2021 (USD Million)
Table 73 North America: Market Size, By Toxicity Endpoint & Test, 2014 - 2021 (USD Million)
Table 74 North America: Market Size, By Technology, 2014 - 2021 (USD Million)
Table 75 North America: Market Size, By Method, 2014 - 2021 (USD Million)
Table 76 North America: Market Size, By Industry, 2014 - 2021 (USD Million)
Table 77 U.S.: Market Size, By Product, 2014 - 2021 (USD Million)
Table 78 U.S.: Market Size, By Type, 2014 - 2021 (USD Million)
Table 79 U.S.: Market Size, By Toxicity Endpoint & Test, 2014 - 2021 (USD Million)
Table 80 U.S.: Market Size, By Technology, 2014 - 2021 (USD Million)
Table 81 U.S.: Market Size, By Method, 2014 - 2021 (USD Million)
Table 82 U.S.: Market Size, By Industry, 2014 - 2021 (USD Million)
Table 83 Canada: Market Size, By Product, 2014 - 2021 (USD Million)
Table 84 Canada: Market Size, By Type, 2014 - 2021 (USD Million)
Table 85 Canada: Market Size, By Toxicity Endpoint & Test, 2014 - 2021 (USD Million)
Table 86 Canada: Market Size, By Technology, 2014 - 2021 (USD Million)
Table 87 Canada: Market Size, By Method, 2014 - 2021 (USD Million)
Table 88 Canada: Market Size, By Industry, 2014 - 2021 (USD Million)
Table 89 Asia: Market Size, By Product, 2014 - 2021 (USD Million)
Table 90 Asia: Market Size, By Type, 2014 - 2021 (USD Million)
Table 91 Asia: Market Size, By Toxicity Endpoint & Test, 2014 - 2021 (USD Million)
Table 92 Asia: Market Size, By Technology, 2014 - 2021 (USD Million)
Table 93 Asia: Market Size, By Method, 2014 - 2021 (USD Million)
Table 94 Asia: Market Size, By Industry, 2014 - 2021 (USD Million)
Table 95 RoW: Market Size, By Product, 2014 - 2021 (USD Million)
Table 96 RoW: Market Size, By Type, 2014 - 2021 (USD Million)
Table 97 RoW: Market Size, By Toxicity Endpoint & Test, 2014 - 2021 (USD Million)
Table 98 RoW: Market Size, By Technology, 2014 - 2021 (USD Million)
Table 99 RoW: Market Size, By Method, 2014 - 2021 (USD Million)
Table 100 RoW: Market Size, By Industry, 2014 - 2021 (USD Million)
Table 101 Market Developments Between January 2013 and May 2016
Table 102 New Product Launches and Product Upgrades, 2013 - 2016
Table 103 Acquisitions, 2013 - 2016
Table 104 Agreements, Collaborations, and Partnerships, 2013 - 2016
Table 105 New Service Launch, 2013 - 2016
Table 106 Expansions, 2013 - 2016
Table 107 Other Developments, 2013 - 2016

List of Figures

Figure 1 Research Design
Figure 2 Market Size Estimation Methodology: Bottom-Up Approach
Figure 3 Market Size Estimation Methodology: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 In Vitro Toxicology Testing Market Size, By Product, 2016 vs 2021 (USD Million)
Figure 7 Market Size, By Type, 2016 vs 2021 (USD Million)
Figure 8 Market Size, By Toxicity Endpoints & Tests, 2016 vs 2021 (USD Million)
Figure 9 Market Size, By Technology, 2016 vs 2021 (USD Million)
Figure 10 Market Size, By Method, 2016 vs 2021 (USD Million)
Figure 11 Market Size, By Industry, 2016 vs 2021 (USD Million)
Figure 12 Market, By Geography, 2016 (USD Million)
Figure 13 Market Size, By Region, 2016 vs 2021 (USD Million)
Figure 14 Increase in R&D Spending to Drive Market Growth
Figure 15 OMICS Technologies to Command the Largest Market Share in 2016
Figure 16 Asia to Register Highest Growth During the Forecast Period
Figure 17 Asia Holds Lucrative Growth Opportunities in the Market
Figure 18 Market Segmentation
Figure 19 Opposition to Animal Testing Will Drive the Market
Figure 20 Increasing R&D Investments in the Pharma Industry Boosting the Growth of the Market
Figure 21 Direct Distribution, the Preferred Strategy By Prominent Companies
Figure 22 Porter’s Five Forces Analysis (2016): Presence of Large Number of Manufacturing Firms Increases Competition
Figure 23 Market, By Product
Figure 24 Assays Segment Commands the Largest Share of the Market in 2016
Figure 25 Bacterial Toxicity Assays Command the Largest Share of the In Vitro Toxicology Testing Market for Assays in 2016
Figure 26 Asia is the Fastest-Growing Regional Segment in the Assays Market During the Forecast Period
Figure 27 Europe Will Be the Largest Regional Segment in the Bacterial Toxicity Assays Market
Figure 28 Asia is the Fastest-Growing Regional Segment in the Enzyme Toxicity Assays Market During the Forecast Period
Figure 29 Europe Will Be the Largest Regional Segment in the Cell-Based Elisa and Western Blots in 2016
Figure 30 Asia, the Fastest-Growing Regional Segment in the Market for Receptor-Binding Assays During the Forecast Period
Figure 31 Europe, the Largest Regional Segment in the Market for Tissue Culture Assays in 2016
Figure 32 Asia is the Fastest-Growing Regional Segment in the Market for Other Assays During the Forecast Period
Figure 33 Asia is the Fastest-Growing Regional Segment in the Market for Services During the Forecast Period
Figure 34 Europe Commands the Largest Share of the Market for Reagents & Labware in 2016
Figure 35 ADME to Command the Largest Share of the In Vitro Toxicology Testing Type Market in 2016
Figure 36 Europe to Form the Largest Regional Segment of the ADME Market in 2016
Figure 37 Dose Response to Command the Largest Share of the In Vitro Toxicology Testing Market in 2016
Figure 38 Asia is the Fastest-Growing Regional Segment in the Dose Market During the Forecast Period
Figure 39 Europe to Form the Largest Regional Segment of the Dose Response Market in 2016
Figure 40 Asia is the Fastest-Growing Regional Segment in the Threshold Dose Market During the Forecast Period
Figure 41 Europe to Form the Largest Regional Segment of the Toxic Substance Market in 2016
Figure 42 Systemic Toxicity to Command the Largest Share of the In Vitro Toxicology Testing Market in 2016
Figure 43 Europe to Form the Largest Regional Segment of the Systemic Toxicity Market in 2016
Figure 44 Europe to Form the Largest Regional Segment of the Dermal Toxicity Market in 2016
Figure 45 Europe to Form the Largest Regional Segment of the Carcinogenicity Market in 2016
Figure 46 Asia is the Fastest-Growing Regional Segment in the Ocular Toxicity Market During the Forecast Period
Figure 47 Europe to Form the Largest Regional Segment of Skin Sensitization & Irritation Market in 2016
Figure 48 Asia is the Fastest-Growing Regional Segment in the Genotoxicity Market During the Forecast Period
Figure 49 Europe to Form the Largest Regional Segment of the Neurotoxicity Market in 2016
Figure 50 Asia is the Fastest-Growing Regional Segment in the Organ Toxicity Market During the Forecast Period
Figure 51 Asia is the Fastest-Growing Regional Segment in the Other Toxicity Endpoints & Tests Market During the Forecast Period
Figure 52 OMICS Technologies to Command the Largest Share of the In Vitro Toxicology Testing Technology Market in 2016
Figure 53 Genomics to Command the Largest Share of the In Vitro Toxicology Testing OMICS Technologies Market in 2016
Figure 54 Europe to Command the Largest Share of the OMICS Technologies Segment in 2016
Figure 55 Europe to Form the Largest Regional Segment of the Genomics Market in 2016
Figure 56 Asia is the Fastest-Growing Regional Segment in the Proteomics Market During the Forecast Period
Figure 57 Europe, the Largest Regional Segment of the Metabolomics Market in 2016
Figure 58 Asia, the Fastest-Growing Regional Segment in the Transcriptomics Market During the Forecast Period
Figure 59 Europe to Dominate the Toxicogenomics Market in the Forecast Period in 2016
Figure 60 Asia is the Fastest-Growing Regional Segment in the Cell Culture Technology Market During the Forecast Period
Figure 61 Europe to Command the Largest Share of the High-Throughput Technologies Segment in 2016
Figure 62 Europe to Command the Largest Share of the Molecular Imaging Technologies Segment in 2016
Figure 63 In Silico Methods to Command the Largest Share of the In Vitro Toxicology Testing Method Market in 2016
Figure 64 Asia is the Fastest-Growing Regional Segment in the In Silico Methods Market During the Forecast Period
Figure 65 Europe to Form the Largest Regional Segment of the Biochemical Assays Market in 2016
Figure 66 Europe to Form the Largest Regional Segment of the Cellular Assays Market in 2016
Figure 67 Asia Will Be the Fastest-Growing Regional Segment in the Ex Vivo Models Market During the Forecast Period
Figure 68 Cosmetics & Household Products Will Be the Largest Industry Segment in 2016
Figure 69 Asia, the Fastest-Growing Regional Segment in the In Vitro Toxicology Testing Market for Cosmetics & Household Products During the Forecast Period
Figure 70 Urine Screening Segment Commands the Largest Share of the In Vitro Toxicology Testing Market for Diagnostics in 2016
Figure 71 Asia is the Fastest-Growing Regional Segment in the Diagnostics Market During the Forecast Period
Figure 72 Europe Will Be the Largest Regional Segment in the Urine Screening Market Between 2016 and 2021
Figure 73 Europe Will Be the Largest Regional Segment in the Alcohol Screening Market Between 2016 and 2021
Figure 74 Europe Will Be the Largest Regional Segment in the Oral Fluid Screening Market Between 2016 and 2021
Figure 75 Europe Will Be the Largest Regional Segment in the Hair Screening Market Between 2016 and 2021
Figure 76 Europe Will Be the Largest Regional Segment in the Other Diagnostics Market Between 2016 and 2021
Figure 77 Asia to Witness Highest Growth in the In Vitro Toxicology Testing Market for Pharmaceuticals During the Forecast Period
Figure 78 Europe to Command the Largest Share of the Food Industry Segment in 2016
Figure 79 Europe to Command the Largest Share of the Chemicals Segment in 2016
Figure 80 In Vitro Toxicology Testing Market Segmentation, By Region: Market Size and Growth Rate, 2016-2021
Figure 81 Asian Market to Grow at the Highest Rate (2016 to 2021)
Figure 82 Europe: In Vitro Toxicology Testing Market Snapshot (2016)
Figure 83 Assays, the Largest Product Segment in Europe in 2016
Figure 84 ADME Segment Dominates the European In Vitro Toxicology Testing Market, By Type
Figure 85 Systemic Toxicity, the Largest Toxicity Endpoint & Test Segment in Europe
Figure 86 OMICS Technologies Command Largest Share of the European Market in 2016
Figure 87 In Silico Methods, the Largest Methods Segment in Europe
Figure 88 Cosmetics & Household Products Segment Commands Largest Share of the European Market in 2016
Figure 89 North America: In Vitro Toxicology Testing Market Snapshot
Figure 90 Canada to Grow at the Highest Rate in North America
Figure 91 Assays, the Largest Product Segment in North America in 2016
Figure 92 ADME Segment Dominates the North American In Vitro Toxicology Testing Market
Figure 93 Systemic Toxicity, the Largest Toxicity Endpoints & Tests Segment in North America in 2016
Figure 94 OMICS Technologies Segment Commands Largest Share of the North American Market in 2016
Figure 95 In Silico Methods, the Largest Method Segment in North America
Figure 96 Cosmetics & Household Products Segment Commands Largest Share of the North American Market in 2016
Figure 97 Assays, the Largest Product Segment in the U.S. in 2016
Figure 98 ADME Segment Dominates the U.S. In Vitro Toxicology Testing Market
Figure 99 Systemic Toxicity, the Largest Toxicity Endpoints & Tests Segment in U.S. in 2016
Figure 100 OMICS Technologies Segment Commands Largest Share of the U.S. Market in 2016
Figure 101 In Silico Methods, the Largest Methods Segment in the U.S.
Figure 102 Cosmetics & Household Products Segment Commands Largest Share of the U.S. Market in 2016
Figure 103 Assays, the Largest Product Segment in Canada in 2016
Figure 104 ADME Segment Dominates the Canada In Vitro Toxicology Testing Market
Figure 105 Systemic Toxicity, the Largest Toxicity Endpoints & Tests Segment in Canada in 2016
Figure 106 OMICS Technologies Segment Commands Largest Share of the Canada Market in 2016
Figure 107 In Silico Methods, the Largest Methods Segment in Canada
Figure 108 Cosmetics & Household Products Segment Commands Largest Share of the Canada Market in 2016
Figure 109 Asia: In Vitro Toxicology Testing Market Snapshot
Figure 110 Assays, the Largest Product Segment in Asia in 2016
Figure 111 ADME Segment Dominates the Asia In Vitro Toxicology Testing Market
Figure 112 Systemic Toxicity, the Largest Toxicity Endpoints & Tests Segment in Asia in 2016
Figure 113 OMICS Technologies Segment Commands Largest Share of the Asia Market in 2016
Figure 114 In Silico Methods, the Largest Methods Segment in Asia
Figure 115 Cosmetics & Household Products Segment Commands Largest Share of the Asia Market in 2016
Figure 116 RoW: In Vitro Toxicology Testing Market Snapshot (2016)
Figure 117 Assays, the Largest Product Segment in RoW in 2016
Figure 118 ADME Segment Dominates the RoW In Vitro Toxicology Testing Market
Figure 119 Systemic Toxicity, the Largest Toxicity Endpoints & Tests Segment in RoW in 2016
Figure 120 OMICS Technologies Segment Commands Largest Share of the RoW Market in 2016
Figure 121 In Silico Methods, the Largest Methods Segment in RoW
Figure 122 Cosmetics & Household Products Segment Commands Largest Share of the RoW Market in 2016
Figure 123 Key Developments in the In Vitro Toxicology Testing Market, 2013 - 2016
Figure 124 Top Companies in the In Vitro Toxicology Testing Market, 2016
Figure 125 Financial Performances of Leading Market Players, 2015
Figure 126 Company Snapshot: Agilent Technologies, Inc.
Figure 127 Company Snapshot: Laboratory Corporation of America Holdings
Figure 128 Company Snapshot: Bio-Rad Laboratories, Inc.
Figure 129 Company Snapshot: General Electric Company
Figure 130 Company Snapshot: Eurofins Scientific SE
Figure 131 Company Snapshot: Merck & Co, Inc. (Parent Company of Bioreliance)
Figure 132 Company Snapshot: Thermo Fisher Scientific, Inc.
Figure 133 Company Snapshot: Charles River Laboratories International, Inc.
Figure 134 Company Snapshot: Catalent
Figure 135 Company Snapshot: Cyprotex

Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Catalent
  • Covance
  • Cyprotex
  • Eurofins Scientific SE
  • General Electric Company
  • MORE

The global in vitro toxicology testing market is expected to reach USD 27.36 Billion by 2021 from USD 14.15 Billion in 2016, at a CAGR of 14.1% between 2016 and 2021. The major drivers for the market include opposition to animal testing, new & promising technologies, increasing R&D to detect toxicity at early stages and insufficient databases to facilitate the use of in vitro test methods are driving the growth of the global market. The growing demand for in vitro toxicology testing in the European market will provide new growth opportunities for this market.

The report provides a granular understanding of the in vitro toxicology testing market. This report segments the global market on the basis of product, type, toxicity endpoints & tests, technology, method, industry and geography. The product segments included in this report are assays, reagents & labware, and services. The assays segment accounts for the largest share of the global market in 2016.

The toxicity endpoints & tests segment includes systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, skin sensitization & Irritation, genotoxicity, neurotoxicity, and organ toxicity. The technology segment is segmented into omics technologies, cell culture technology, high-throughput technologies, and molecular imaging technologies.

The method segments included in this report in silico methods, biochemical assays, cellular assays, and ex vivo models. The industry segment includes cosmetics & household products, pharmaceutical industry, diagnostics, chemical industry, and food industry.

The geographic segments included in this report are Europe, North America, Asia, and the Rest of the World (RoW). The report maps each product, type, toxicity endpoints & tests, technology, method, industry segment in 6 geographic and regional segments. Geographic analysis reveals that Europe accounted for the largest share of the global in vitro toxicology testing market in 2016. Growth in this market can be attributed to rapidly increasing aging population and the subsequent rise in chronic diseases, costly technological advances. Similarly Asia is estimated to be the fastest growing market of the global market in 2015. The wide applications of in vitro toxicology testing products in testing of different endpoints done by various industries such as cosmetics, pharmaceutical industry are the major driving factor for market in this region.

The major players in this market include Agilent Technologies, Inc. (U.S.), Covance, Inc. (A subsidiary of LabCorp) (U.S.), Bio-Rad Laboratories, Inc. (U.S.), General Electric Company (U.S.), Eurofins Scientific SE (Luxembourg), BioReliance, Inc. (A subsidiary of Merck & Co, Inc.) (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.), and Cyprotex (U.K.).

Exteneded Description

"In Vitro Toxicology Testing Market by Product, Type (ADME), Toxicity Endpoints & Tests (Carcinogenicity, Dermal Toxicity, Genotoxicity), Technology (Genomics, Transcriptomics), Method (Cellular Assays), Industry (Pharmaceutical) - Global Forecast to 2021"

Toxicity testing of new compounds is essential in drug development, as identifying the potential toxicity at an early stage in drug discovery can save both time and developmental costs, and also reduce the likelihood of late-stage failure.

Opposition to animal testing, new & promising technologies, increasing R&D to detect toxicity at early stages and insufficient databases to facilitate the use of in vitro test methods are driving factors of the in vitro toxicology testing market. On the other hand lack of in vitro models to detect autoimmunity and immunostimulation and predictive ability of in vitro testing over in vivo testing are the major factor restraining the growth of this market.

This report segments the global in vitro toxicology testing market by product, type, toxicity endpoints & tests, technology, method, industry, and geography. By product, the market includes assays, reagents & labware, and services. The assays segment is further divided into bacterial toxicity assays, enzyme toxicity assays, cell-based ELISA and Western blots, receptor binding assays, tissue culture assays. Furthermore, the type segment includes ADME, dose, toxic substance. The toxicity endpoints & tests segments included in this report are systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, skin sensitization & irritation, genotoxicity, neurotoxicity, and organ toxicity. The method segments includes in silico methods, biochemical assays, cellular assays, and ex vivo models. The industry segment included in this report is cosmetics, pharmaceutical, diagnostics, chemical, and food.

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global in vitro toxicology testing market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

Geographic analysis reveals that Europe accounted for the largest share of the global in vitro toxicology testing market in 2016. Growth in this market can be attributed to the increasing aging population, costly technological advances, increasing awareness of the importance of a healthy lifestyle.

The major players in this market include Agilent Technologies, Inc. (U.S.), Covance, Inc. (A subsidiary of LabCorp) (U.S.), Bio-Rad Laboratories, Inc. (U.S.), General Electric Company (U.S.), Eurofins Scientific SE (Luxembourg), BioReliance, Inc. (A subsidiary of Merck & Co, Inc.) (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.), and Cyprotex (U.K.).

Target Audience for this Report:

- Healthcare provider/diagnostics laboratories
- Academic research institutes
- Pharmaceutical companies
- Chemical companies
- Food & beverage manufacturers-
- Contract research organizations (CROs)
- Market research & consulting firms

Global In Vitro Toxicology Testing Market, by Product

- Assays
- Bacterial Toxicity Assays
- Enzyme Toxicity Assays
- Cell-Based ELISA and Western Blots
- Receptor Binding Assays
- Tissue Culture Assays
- Other Assays
- Reagents & Labware
- Services

Global In Vitro Toxicology Testing Market, by Type

- ADME (Absorption, Distribution, Metabolism , and Excretion)
- Dose
- Toxic Substance

Global In Vitro Toxicology Testing Market, by Toxicity Endpoints & Tests

- Systemic Toxicity
- Dermal Toxicity
- Carcinogenicity
- Ocular Toxicity
- Skin Sensitization & Irritation
- Genotoxicity
- Neurotoxicity
- Organ Toxicity
- Other Toxicity Endpoints & Tests

Global In Vitro Toxicology Testing Market, by Technology

- OMICS Technologies
- Genomics
- Proteomics
- Transcirptomics
- Metabolomics
- Toxicogenomics
- Cell Culture Technology
- High-throughput Technologies
- Molecular Imaging Technologies

Global In Vitro Toxicology Testing Market, by Method

- In Silico Method
- Biochemical Assays
- Cellular Assays
- Ex Vivo Models

Global In Vitro Toxicology Testing Market, by Industry

- Cosmetics & Household Products
- Pharmaceutical Industry
- Diagnostics
- Urine Screening
- Alcohol Screening
- Oral Fluid Screening
- Hair Screening
- Other Diagnostics
- Chemical Industry
- Food Industry

Global In Vitro Toxicology Testing Market, by Geography

- North America
- U.S.
- Canada
- Europe
- Asia
- Rest of the World

Note: Product cover images may vary from those shown
4 of 5

- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Bioreliance, Inc. (A Subsidiary of Merck & Co, Inc.)
- Catalent
- Charles River Laboratories International, Inc.
- Covance
- Cyprotex
- Eurofins Scientific SE
- General Electric Company
- Thermo Fisher Scientific, Inc.

Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Luminex Corporation
  • Alere Inc.
  • Thermo Fisher Scientific Inc
  • Siemens AG
  • Genzyme Corporation
  • Quidel Corporation